Skip to main content
Home > Week in Review > Deals

Chronological Index of : Deals

 Current Issue
  • Abpro, Brigham and Womens Hospital deal

    Abpro, Woburn, Mass. Brigham and Womens Hospital, Boston, Mass. Business: Pharmaceuticals, Antibodies Abpro and the hospital partnered to discover and co-develop mAbs for fibrosis. The partners will use Abpros …

    Published on 5/30/2016
  • Abpro, Massachusetts General Hospital deal

    Abpro, Woburn, Mass. Massachusetts General Hospital, Boston, Mass. Business: Cancer, Antibodies, Inflammation Abpro and the hospital partnered to discover and co-develop mAbs in cancer, inflammation and autoimmunity. …

    Published on 5/30/2016
  • Amarantus BioScience, Avant Diagnostics deal

    Amarantus BioScience Holdings Inc. (OTCQX:AMBS), San Francisco, Calif. Avant Diagnostics Inc. (OTCQB:AVDX), Scottsdale, Ariz. Business: Diagnostic Avant acquired Amarantus BioSciences Amarantus Diagnostics Inc. …

    Published on 5/30/2016
  • Astellas, Daiichi Sankyo, Takeda deal

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Pharmaceuticals Astellas, Daiichi Sankyo and Takeda …

    Published on 5/30/2016
  • Astellas, Thunderbolt deal

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Thunderbolt Pharma Inc., South San Francisco, Calif. Business: Autoimmune Newco Thunderbolt acquired Astellas preclinical dual antagonist program targeting BLyS (BAFF) and…

    Published on 5/30/2016
  • Boehringer Ingelheim, Horizon Pharma deal

    Boehringer Ingelheim GmbH, Ingelheim, Germany Horizon Pharma plc (NASDAQ:HZNP), Dublin, Ireland Business: Musculoskeletal, Inflammation Boehringer Ingelheim granted Horizon exclusive rights to develop and commercialize …

    Published on 5/30/2016
  • Bristol-Myers, Allied Minds deal

    Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Allied Minds plc (LSE:ALM), Boston, Mass. Business: Autoimmune Allied-Bristol Life Sciences, a jointly owned company formed in 2014 by Bristol-Myers Squibb and Allied …

    Published on 5/30/2016
  • Cancer Research UK, Pangaea Biotech deal

    Cancer Research UK, London, U.K. Pangaea Biotech S.A., Barcelona, Spain Business: Cancer Pangaea and Cancer Research UKs commercialization and development arm, Cancer Research Technology (CRT), partnered to develop CRTs…

    Published on 5/30/2016
  • Chugai, Osaka University deal

    Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Osaka University, Osaka, Japan Business: Pharmaceuticals Chugai will provide the universitys Immunology Frontier Research Center Y1 billion ($9.1 million) per …

    Published on 5/30/2016
  • Evotec, Roche, Genentech deal

    Evotec AG (Xetra:EVT), Hamburg, Germany Roche (SIX:ROG;OTCQX:RHHBY), Basel, Switzerland Genentech Inc., South San Francisco, Calif. Business: High throughput screening, Chemistry Evotec and Roches Genentech unit …

    Published on 5/30/2016
  • Fujifilm, The Michael J. Fox Foundation For Parkinsons Research deal

    Fujifilm Holdings Corp. (Tokyo:4901), Tokyo, Japan The Michael J. Fox Foundation For Parkinsons Research, New York, N.Y. Business: Neurology, Gene/Cell therapy Fujifilms Cellular Dynamics International Inc. company and …

    Published on 5/30/2016
  • HTG Molecular Diagnostics, Bristol-Myers deal

    HTG Molecular Diagnostics Inc. (NASDAQ:HTGM), Tucson, Ariz. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Cancer HTG and Bristol-Myers Squibb partnered to evaluate immuno-oncology molecular profiling in …

    Published on 5/30/2016
  • Inovalon, Bristol-Myers deal

    Inovalon Holdings Inc. (NASDAQ:INOV), Bowie, Md. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Supply/Service The companies will use Inovalons cloud-based data analytics and data-driven intervention …

    Published on 5/30/2016
  • Ionis Pharmaceuticals, University of Texas MD Anderson Cancer Center deal

    Ionis Pharmaceuticals Inc. (NASDAQ:IONS), Carlsbad, Calif. University of Texas MD Anderson Cancer Center, Houston, Texas Business: Cancer Ionis and MD Anderson Cancer Center partnered to discover and develop cancer …

    Published on 5/30/2016
  • Kemwell, Recipharm deal

    Kemwell Biopharma Pvt. Ltd., Bangalore, India Recipharm AB (CSE:RECI B), Jordbro, Sweden Business: Supply/Service Recipharm acquired Kemwells contract development and manufacturing operations in the U.S., Sweden and …

    Published on 5/30/2016
  • MorphoSys, University of Texas MD Anderson Cancer Center deal

    MorphoSys AG (Xetra:MOR), Martinsried, Germany University of Texas MD Anderson Cancer Center, Houston, Texas Business: Cancer, Antibodies MorphoSys and MD Anderson Cancer Center partnered to use MorphoSys Ylanthia …

    Published on 5/30/2016
  • Nanosphere, Luminex deal

    Nanosphere Inc. (NASDAQ:NSPH), Northbrook, Ill. Luminex Corp. (NASDAQ:LMNX), Austin, Texas Business: Diagnostic Luminex increased its bid to acquire fellow diagnostic company Nanosphere to $1.70 per share in cash, or …

    Published on 5/30/2016
  • Novartis, PDL BioPharma deal

    Novartis AG (NYSE:NVS;SIX:NOVN), Basel, Switzerland PDL BioPharma Inc. (NASDAQ:PDLI), Incline Village, Nev. Business: Cardiovascular Novartis granted newly launched PDL subsidiary, Noden Pharma DAC, exclusive, worldwide…

    Published on 5/30/2016
  • Oryzon, Roche deal

    Oryzon Genomics S.A., Barcelona, Spain Roche (SIX:ROG;OTCQX:RHHBY), Basel, Switzerland Business: Cancer, Hematology Oryzon and Roche extended by one year until March 2017 a collaborative research program to explore the …

    Published on 5/30/2016
  • Roche, Strekin deal

    Roche (SIX:ROG;OTCQX:RHHBY), Basel, Switzerland Strekin AG, Basel, Switzerland Business: Inflammation Roche granted Strekin exclusive, worldwide rights to pamapimod (R1503). The p38 mitogen-activated protein kinase (p38…

    Published on 5/30/2016
  • Theranostics Health, Avant Diagnostics deal

    Theranostics Health Inc., Rockville, Md. Avant Diagnostics Inc. (OTCQB:AVDX), Scottsdale, Ariz. Business: Diagnostic Avant acquired fellow diagnostic company Theranostics Health for 25 million shares of Avant valued at…

    Published on 5/30/2016
  • Trianni, Evotec deal

    Trianni Inc., Emeryville, Calif. Evotec AG (Xetra:EVT), Hamburg, Germany Business: Functional genomics Trianni granted Evotec non-exclusive rights to use the Trianni Mouse platform for antibody discovery. Evotec will …

    Published on 5/30/2016
  • Vectura, Propeller Health deal

    Vectura Group plc (LSE:VEC), Chippenham, U.K. Propeller Health, Madison, Wis. Business: Drug delivery The companies partnered to develop a digitally connected inhaler to treat chronic respiratory diseases. Vectura is …

    Published on 5/30/2016
  • XenoPort, Arbor Pharmaceuticals deal

    XenoPort Inc. (NASDAQ:XNPT), Santa Clara, Calif. Arbor Pharmaceuticals Inc., Atlanta, Ga. Business: Neurology Specialty pharma Arbor will acquire XenoPort for $7.03 per share in a cash deal the companies say values …

    Published on 5/30/2016
  • Albany Molecular Research, Cedarburg Hauser deal

    Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Cedarburg Hauser Pharmaceuticals Inc., Grafton, Wis. Business: Supply/Service Albany Molecular completed its acquisition of contract developer and manufacturer …

    Published on 4/14/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993